{"schema_version":"secwatch.filing_event.v1","accession":"0001510964-22-000048","form_type":"8-K","ticker":"CVSI","cik":"0001510964","company_name":"CV Sciences, Inc.","filed_at":"2022-06-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.974777+00:00","generated_at":"2026-06-25T05:27:06.333228+00:00","sec_items":["5.02","5.07"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"CV Sciences stockholders approve 4x share increase, reverse split up to 1:400; Board reduced to 3","bullets":["Stockholders elected Dr. Joseph Maroon and Joseph Dowling as directors; 3 prior directors did not stand for re-election.","Authorized shares increased from 200M to 800M; common stock authorized from 190M to 790M.","Reverse stock split approved (1:10 to 1:400), at Board discretion before May 30, 2025.","Board size reduced to 3 members to cut costs, leaving one vacancy.","Ratification of Haskell & White as auditor for FY2022 passed; advisory vote on executive comp approved."],"urls":{"canonical":"https://secwatch.observer/filing/0001510964-22-000048","json":"https://secwatch.observer/filing/0001510964-22-000048.json","markdown":"https://secwatch.observer/filing/0001510964-22-000048.md","text":"https://secwatch.observer/filing/0001510964-22-000048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1510964/000151096422000048/0001510964-22-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1510964/000151096422000048/cvsi-20220526.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T05:27:06.333228+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}